Short answer
Cardinal Health (CAH) filed an 8-K current report with the SEC on August 11, 2026 reporting Item 2.03 (Creation of a Direct Financial Obligation), Item 1.01 (Entry into a Material Definitive Agreement), Item 1.02 (Termination of a Material Definitive Agreement). $4.0B unsecured revolving credit facility available through August 7, 2031.
Cardinal Health 8-K event analysis
AI summary of each reported item and its exhibits
Item 1.01 · Entry into a Material Definitive Agreement
- $4.0B unsecured revolving credit facility available through August 7, 2031
- Replaces existing 364-day and five-year revolvers plus receivables sale facility
- Two-year maturity extension permitted, subject to specified conditions
- Financial covenant: consolidated net leverage ratio no greater than 4.00x
- General corporate purposes, including liquidity support and refinancing flexibility
Item 1.02 · Termination of a Material Definitive Agreement
- Cardinal Health terminated $2.0 billion five-year and $1.0 billion 364-day revolving credit facilities on August 7, 2026
- Terminated $1.0 billion committed receivables sale program and related performance guarantee
- Replacement Credit Agreement under Item 1.01 preserves financing access through new facilities
- No termination penalties, limiting immediate financial impact
- Changes consolidate Cardinal Health’s liquidity arrangements, while commercial paper dealer relationships continue with BOA and JPM affiliates
Item 2.03 · Creation of a Direct Financial Obligation
- Item 2.03 points to Item 1.01 for debt or other direct financial obligation details
- Investor impact depends on the referenced agreement’s amount, pricing, maturity and borrowing purpose
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Cardinal Health 8-K filings
Get the next CAH 8-K as it lands
Follow CAH for push alerts, or ask the research agent what this filing means.